← Back to Search

Diagnostic Test

LINFU™ for Pancreatic Adenocarcinoma

N/A

Waitlist Available

Led By Scott Corbett, MD, FASGE

Research Sponsored by Adenocyte, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

Study Summary

This trial is testing a new method to detect pancreatic cancer using ultrasound and analysis of pancreatic fluid.

Eligible Conditions

Pancreatic Adenocarcinoma
Dysplasia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Does LINFU™ yield an adequate number of cells that can be used to help diagnose pancreatic precancers and cancers?

Trial Design

1Treatment groups

Experimental Treatment

Group I: The LINFU™ testExperimental Treatment1 Intervention

LINFU™ to increase sensitivity of pancreatic juice cytology LINFU™ consists of analysis of pancreatic fluid collected with the help of low intensity non-focused ultrasound excitation of the pancreas. Lumason, will be used to create bubbles and possibly increase the number of pancreatic cell we collect for the study. Secretin is also used to increase the number of pancreatic cell excretion to maximize the number of cells collected.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

LINFU™

2021

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Adenocyte, LLCLead Sponsor

5 Previous Clinical Trials

3,500 Total Patients Enrolled

Scott Corbett, MD, FASGEPrincipal InvestigatorSuncoast Endoscopy of Sarasota (a division of Florida Digestive Health Specialists)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies for participation in this trial?

"This clinical trial seeks 10 individuals diagnosed with adenocarcinoma, ranging from 18 to 90 years old. All genders are accepted, but those interested must have IRB-approved consent and be of legal age."

Answered by AI

Does the trial include individuals aged 70 or above?

"As per the trial's enrollment prerequisites, applicants must be between 18 and 90 years old. There are 7 separate studies for those younger than 18 and another 793 trials for people over 65."

Answered by AI

Is the enrollment period still open for this research study?

"Clinicaltrials.gov indicates that this particular medical study, initially posted on October 21st 2021 and revised on August 29th 2022 is not presently recruiting patients. Nonetheless, there are 794 other studies actively taking in volunteers at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Proof-of-Concept Study Evaluating LINFU™

2021. "A Proof-of-Concept Study Evaluating LINFU™". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05161013.